Literature DB >> 1975175

The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

W P Arend1, B A Michel, D A Bloch, G G Hunder, L H Calabrese, S M Edworthy, A S Fauci, R Y Leavitt, J T Lie, R W Lightfoot.   

Abstract

Criteria for the classification of Takayasu arteritis were developed by comparing 63 patients who had this disease with 744 control patients with other forms of vasculitis. Six criteria were selected for the traditional format classification: onset at age less than or equal to 40 years, claudication of an extremity, decreased brachial artery pulse, greater than 10 mm Hg difference in systolic blood pressure between arms, a bruit over the subclavian arteries or the aorta, and arteriographic evidence of narrowing or occlusion of the entire aorta, its primary branches, or large arteries in the proximal upper or lower extremities. The presence of 3 or more of these 6 criteria demonstrated a sensitivity of 90.5% and a specificity of 97.8%. A classification tree also was constructed with 5 of these 6 criteria, omitting claudication of an extremity. The classification tree demonstrated a sensitivity of 92.1% and a specificity of 97.0%.

Entities:  

Mesh:

Year:  1990        PMID: 1975175     DOI: 10.1002/art.1780330811

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  479 in total

1.  A 69-year-old woman with intermittent claudication and elevated ESR.

Authors:  M L Amoedo; M P Marco; M D Boquet; S Muray; J M Piulats; M J Panades; J Ramos; E Fernandez
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

2.  CLINICAL PROFILE OF TAKAYASU'S ARTERITIS.

Authors:  S K Sharma; K V Sangameswaran; S P Kalra
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis.

Authors:  Myles Webb; Anthony Chambers; Adil AL-Nahhas; Justin C Mason; Lucy Maudlin; Lucy Rahman; John Frank
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-01-17       Impact factor: 9.236

Review 4.  Takayasu arteritis: a review.

Authors:  S L Johnston; R J Lock; M M Gompels
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

5.  Detection of alterations in brain glucose metabolism by positron emission tomography in Takayasu's arteritis.

Authors:  Stefan M Weiner; Peter Vaith; Ulrich A Walker; Ingo Brink
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 6.  Tuberculosis and Takayasu arteritis: case-based review.

Authors:  Moritz K Jansson; Hilte F Geerdes-Fenge; Antje Kangowski; Christian Kneitz; Emil C Reisinger
Journal:  Rheumatol Int       Date:  2019-01-03       Impact factor: 2.631

7.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease.

Authors:  Martin A Walter; Ralph A Melzer; Christian Schindler; Jan Müller-Brand; Alan Tyndall; Egbert U Nitzsche
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-03-04       Impact factor: 9.236

8.  Cerebrovascular events in Takayasu arteritis: a multicenter case-controlled study.

Authors:  Priscille Couture; Thibaud Chazal; Charlotte Rosso; Julien Haroche; Anne Léger; Baptiste Hervier; Sandrine Deltour; Zahir Amoura; Fleur Cohen Aubart
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

9.  Sudden cardiac arrest with acute myocardial infarction induced by left subclavian artery occlusion in a patient with prior coronary artery bypass surgery.

Authors:  Ki-Bum Won; Yun-Hyeong Cho; Deok-Kyu Cho
Journal:  Korean Circ J       Date:  2012-12-31       Impact factor: 3.243

10.  Childhood vasculitides in Turkey: a nationwide survey.

Authors:  Seza Ozen; Aysin Bakkaloglu; Ruhan Dusunsel; Oguz Soylemezoglu; Fatih Ozaltin; Hakan Poyrazoglu; Ozgur Kasapcopur; Ozan Ozkaya; Fatos Yalcinkaya; Ayse Balat; Nurdan Kural; Osman Donmez; Harika Alpay; Ali Anarat; Sevgi Mir; Ayfer Gur-Guven; Ferah Sonmez; Faysal Gok
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.